Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
HZNP was delisted on the 5th of October, 2023.
196 hedge funds and large institutions have $2.33B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2016 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 69 increasing their positions, 61 reducing their positions, and 42 closing their positions.
210% more call options, than puts
Call options by funds: $73.6M | Put options by funds: $23.7M
13% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 61
10% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 42
3% less funds holding
Funds holding: 202 → 196 (-6)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
23% less capital invested
Capital invested by funds: $3.04B → $2.33B (-$708M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BPCM
Beach Point Capital Management
Santa Monica,
California
|
+$37M |
| 2 |
DM
Deerfield Management
New York
|
+$36M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$29M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$21.9M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$21.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Teacher Retirement System of Texas
Austin,
Texas
|
-$36.9M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$28.1M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$23.5M |
| 4 |
BC
Broadfin Capital
New York
|
-$22.9M |
| 5 |
Goldman Sachs
New York
|
-$19.1M |
HZNP Hedge Fund Activity: Q1 2016 in Review
196 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) for Q1 2016, worth a combined $2.33B — down 23% from $3.04B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of HZNP and 38 opened new positions — a net loss of 4 holders — while 61 trimmed existing stakes and 69 added.
The largest buyer was Beach Point Capital Management, opening a new position worth an estimated $37M. The largest seller was Teacher Retirement System of Texas, cutting an estimated $36.9M.
- 196 institutional investors held Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) as of Q1 2016, down from 202 in Q4 2015.
- Funds reported $2.33B of Horizon Therapeutics Public Limited Company Ordinary Shares stock for Q1 2016, down 23% quarter-over-quarter.
- 38 funds opened new Horizon Therapeutics Public Limited Company Ordinary Shares positions in Q1 2016 and 42 closed out, a net change of -4 holders.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares buyer in Q1 2016 was Beach Point Capital Management, an estimated $37M added.
- The largest Horizon Therapeutics Public Limited Company Ordinary Shares seller in Q1 2016 was Teacher Retirement System of Texas, an estimated $36.9M sold.
Based on aggregated 13F filings for Q1 2016.